GD
LLY icon

Grandfield & Dodd’s Eli Lilly LLY Stock Holding History

Grandfield & Dodd’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.87M Sell
2,035
-10
-0.5% -$10.1K 0.11% 86
2025
Q4 		$2.2M Sell
2,045
-133
-6% -$127K 0.12% 82
2025
Q3 		$1.66M Sell
2,178
-101
-4% -$75.2K 0.09% 97
2025
Q2 		$1.78M Sell
2,279
-249
-10% -$193K 0.1% 92
2025
Q1 		$2.09M Sell
2,528
-146
-5% -$121K 0.13% 79
2024
Q4 		$2.06M Sell
2,674
-25
-0.9% -$20.7K 0.13% 81
2024
Q3 		$2.39M Sell
2,699
-49
-2% -$44.1K 0.14% 76
2024
Q2 		$2.49M Sell
2,748
-142
-5% -$114K 0.16% 76
2024
Q1 		$2.25M Sell
2,890
-70
-2% -$49.8K 0.14% 76
2023
Q4 		$1.73M Sell
2,960
-142
-5% -$82.9K 0.12% 85
2023
Q3 		$1.67M Sell
3,102
-39
-1% -$20.1K 0.12% 81
2023
Q2 		$1.47M Sell
3,141
-160
-5% -$67.1K 0.1% 86
2023
Q1 		$1.13M Hold
3,301
– – 0.08% 99
2022
Q4 		$1.21M Buy
3,301
+380
+13% +$135K 0.09% 94
2022
Q3 		$940K Hold
2,921
– – 0.08% 98
2022
Q2 		$950K Sell
2,921
-150
-5% -$45K 0.07% 101
2022
Q1 		$880K Hold
3,071
– – 0.06% 111
2021
Q4 		$850K Hold
3,071
– – 0.05% 112
2021
Q3 		$710K Hold
3,071
– – 0.05% 117
2021
Q2 		$700K Buy
3,071
+115
+4% +$23.1K 0.05% 117
2021
Q1 		$550K Buy
2,956
+70
+2% +$13.7K 0.04% 126
2020
Q4 		$490K Hold
2,886
– – 0.04% 127
2020
Q3 		$430K Sell
2,886
-200
-6% -$31K 0.04% 131
2020
Q2 		$510K Buy
3,086
+53
+2% +$8.13K 0.05% 122
2020
Q1 		$421K Sell
3,033
-2,832
-48% -$389K 0.05% 125
2019
Q4 		$771K Buy
5,865
+90
+2% +$10.4K 0.07% 109
2019
Q3 		$646K Sell
5,775
-150
-3% -$16.7K 0.06% 117
2019
Q2 		$656K Sell
5,925
-200
-3% -$23.6K 0.06% 114
2019
Q1 		$795K Sell
6,125
-300
-5% -$36.5K 0.08% 103
2018
Q4 		$744K Hold
6,425
– – 0.09% 100
2018
Q3 		$690K Hold
6,425
– – 0.07% 112
2018
Q2 		$548K Buy
6,425
+92
+1% +$7.56K 0.06% 122
2018
Q1 		$490K Hold
6,333
– – 0.05% 124
2017
Q4 		$535K Hold
6,333
– – 0.06% 125
2017
Q3 		$542K Hold
6,333
– – 0.06% 125
2017
Q2 		$521K Hold
6,333
– – 0.06% 129
2017
Q1 		$533K Sell
6,333
-100
-2% -$8.01K 0.07% 119
2016
Q4 		$473K Sell
6,433
-1,328
-17% -$98.9K 0.06% 125
2016
Q3 		$623K Hold
7,761
– – 0.08% 107
2016
Q2 		$611K Buy
7,761
+150
+2% +$11.3K 0.09% 106
2016
Q1 		$548K Sell
7,611
-126
-2% -$9.53K 0.08% 103
2015
Q4 		$652K Hold
7,737
– – 0.1% 97
2015
Q3 		$648K Hold
7,737
– – 0.11% 95
2015
Q2 		$646K Buy
7,737
+450
+6% +$34.3K 0.1% 98
2015
Q1 		$529K Hold
7,287
– – 0.08% 107
2014
Q4 		$503K Sell
7,287
-28
-0.4% -$1.89K 0.08% 116
2014
Q3 		$474K Buy
7,315
+28
+0.4% +$1.77K 0.07% 110
2014
Q2 		$453K Hold
7,287
– – 0.07% 127
2014
Q1 		$429K Hold
7,287
– – 0.07% 124
2013
Q4 		$372K Hold
7,287
– – 0.06% 130
2013
Q3 		$367K Hold
7,287
– – 0.07% 130
2013
Q2 		$358K Buy
+7,287
New +$397K 0.07% 131

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Grandfield & Dodd's LLY Position: Q1 2026 in Review

Grandfield & Dodd reduced its Eli Lilly (LLY) stake by 0.49% in Q1 2026, selling an estimated $10.1K and leaving 2,035 shares worth $1.87M. The position accounts for 0.11% of the portfolio, ranked #86.

Grandfield & Dodd first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.49M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Grandfield & Dodd held 2,035 shares of Eli Lilly worth $1.87M as of Q1 2026.
  • Grandfield & Dodd sold 10 Eli Lilly shares in Q1 2026, an estimated $10.1K.
  • Eli Lilly made up 0.11% of Grandfield & Dodd's portfolio in Q1 2026, its #86 holding.
  • Grandfield & Dodd first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Grandfield & Dodd's Eli Lilly position peaked at $2.49M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Grandfield & Dodd's 13F filing for Q1 2026, filed 7 May 2026.